COMMUNIQUÉS West-GlobeNewswire

UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys
02/10/2025
EAGLE, Idaho, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today [...]
Oxford Treatment Center Brings Flexible Addiction Care to Southaven, Debuts Evening IOP with Public Meet-and-Greet
02/10/2025
SOUTHAVEN, Miss., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Oxford Treatment Center is expanding its outpatient services in Southaven with a new evening intensive outpatient program (IOP). The new evening program is designed to [...]
Algae-C Inc. Announces Completion of Acquisition by Rockcliffe Labs Inc.
02/10/2025
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Algae-C Inc. (“Algae-C”) today announced that it has been acquired by Rockcliffe Labs Inc. (“Rockcliffe Labs”), a Canadian biotechnology venture creation platform. Under the [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/10/2025
BOSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD
02/10/2025
Cirrus’ lead program is a novel AAV gene therapy designed to restore IRAK-M, a central regulator of the eye’s immune homeostasis, so as to prevent AMD progression and preserve central vision IRAK-M levels decrease with [...]
A.D.A.M. Innovations Launches GeneLink, the World’s First Genetics-Powered Ad Platform
02/10/2025
TOKYO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (“A.D.A.M. Innovations”), Japan’s leading genomics and AI company, today announced the official launch of GeneLink , a breakthrough advertising platform [...]
BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program
02/10/2025
Program has honored more than 500 members of the military since its inception Sponsorship honors both local military veterans and healthcare professionals POMPANO BEACH, Fla., Oct. 02, 2025 (GLOBE NEWSWIRE) -- BioStem [...]
AVAVA Named Winner Best Emerging Disruptor Octane High Tech Awards
02/10/2025
Innovative Focal Point Technology™ with ComfortCool™ Delivers Regenerative Aesthetic Treatments Safe for all Skin Tones—Redefining Skin Health from the Inside Out NEWPORT BEACH, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE [...]
Corey A. Collins Promoted to CEO of Tekton Research to Lead Next Era of Growth
02/10/2025
Growth Supports Tekton’s Strategic Focus in CNS and Cardiometabolic research AUSTIN, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Tekton Research, a leading multi-site clinical trial company, is pleased to announce the [...]
George Medicines strengthens global commercialization strategy for GMRx2 with exclusive Biolab Farmacêutica licensing agreement in Brazil
02/10/2025
Biolab Farmacêutica gains exclusive rights in Brazil to GMRx2, an innovative single pill combination of three medicines, including two doses that are lower than those currently available in single pill combinations, [...]
Draig Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of DT-101 for the Treatment of Major Depressive Disorder
02/10/2025
DT-101 is designed to allow effective modulation of the AMPA receptor without compromising safety Phase 2 clinical trial initiation anticipated before the end of 2025 Trial builds on positive Phase 1 study that showed [...]
CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia
02/10/2025
SINGAPORE, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary [...]
AAVantgarde Announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the Treatment of Stargardt Disease
02/10/2025
AAVB-039 addresses the root cause of the disease, benefitting patients with any ABCA4 mutation AAVB-039 is currently being assessed in the CELESTE interventional clinical trial and we continue recruiting in our STELLA [...]
Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
02/10/2025
ANAVEX3-71-SZ-001 achieved its primary endpoint demonstrating safety and tolerability in adults with schizophrenia Encouraging trends observed in biomarkers support continued development NEW YORK, Oct. 02, 2025 (GLOBE [...]
Ocugen to Present at Industry and Investor Conferences in October 2025
02/10/2025
MALVERN, Pa., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that executive [...]
Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
02/10/2025
– Data from ATH434-201 double-blind Phase 2 trial to be featured in oral session and multiple poster presentations – MELBOURNE, Australia and SAN FRANCISCO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: [...]
Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program
02/10/2025
ANAVEX3-71-002 trial achieved its primary endpoint demonstrating safety and tolerability in both male and female adults Oral ANAVEX ® 3-71 tablet exhibits superior pharmacokinetics compared to the current immediate- [...]
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel
02/10/2025
AUSTIN, TX and DURHAM, NC, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) [...]
Premier Health Reports AMP Decision Regarding Subsidiaries in Quebec
02/10/2025
MONTRÉAL, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “ Company ” or “ Premier Health ”), a leading Canadian health tech company, today announced that its subsidiaries, Code Bleu, [...]

Pages